Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Leukemia Research
|
January 23, 2026
Clinical utility of interim bone marrow biopsies in FLT3 mutant acute myeloid leukemia
Vincent Lok, Katie Moffitt, Dahniel Sastow, et al.
Leukemia
|
May 1, 2021
Genomic stratification of myelodysplastic/myeloproliferative neoplasms, unclassifiable: Sorting through the unsorted
Abhishek A Mangaonkar, David M Swoboda, Terra L Lasho, et al.
Leukemia Research
|
June 25, 2023
Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)
Abhishek A Mangaonkar, David M Swoboda, Terra L Lasho, et al.
Leukemia
|
November 2, 2020
PTPN11 mutations are associated with poor outcomes across myeloid malignancies
David M Swoboda, Najla Al Ali, Onyee Chan, et al.
Leukemia Research
|
June 18, 2021
Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy
Anthony M Hunter, Najla Al Ali, Anne Mai, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 15, 2021
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies
Quinto J Gesiotto, David M Swoboda, Rory M Shallis, et al.
American Journal of Hematology
|
February 18, 2022
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Somedeb Ball, Akriti G Jain, Luis E Aguirre, et al.
Hematological Oncology
|
May 16, 2026
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia
Georgio Medawar, Jean-Sebastien Anoma, Elizabeth Hill, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 8, 2021
Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies
Rory M Shallis, Jan Philipp Bewersdorf, David M Swoboda, et al.
Molecular Cell
|
April 3, 2026
U2AF regulates the translation and localization of nuclear-encoded mitochondrial mRNAs
Gloria R Garcia, Murali Palangat, Josquin Moraly, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Leukemia Research
|
January 23, 2026
Clinical utility of interim bone marrow biopsies in FLT3 mutant acute myeloid leukemia
Vincent Lok, Katie Moffitt, Dahniel Sastow, et al.
Leukemia
|
May 1, 2021
Genomic stratification of myelodysplastic/myeloproliferative neoplasms, unclassifiable: Sorting through the unsorted
Abhishek A Mangaonkar, David M Swoboda, Terra L Lasho, et al.
Leukemia Research
|
June 25, 2023
Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)
Abhishek A Mangaonkar, David M Swoboda, Terra L Lasho, et al.
Leukemia
|
November 2, 2020
PTPN11 mutations are associated with poor outcomes across myeloid malignancies
David M Swoboda, Najla Al Ali, Onyee Chan, et al.
Leukemia Research
|
June 18, 2021
Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy
Anthony M Hunter, Najla Al Ali, Anne Mai, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 15, 2021
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies
Quinto J Gesiotto, David M Swoboda, Rory M Shallis, et al.
American Journal of Hematology
|
February 18, 2022
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Somedeb Ball, Akriti G Jain, Luis E Aguirre, et al.
Hematological Oncology
|
May 16, 2026
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia
Georgio Medawar, Jean-Sebastien Anoma, Elizabeth Hill, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 8, 2021
Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies
Rory M Shallis, Jan Philipp Bewersdorf, David M Swoboda, et al.
Molecular Cell
|
April 3, 2026
U2AF regulates the translation and localization of nuclear-encoded mitochondrial mRNAs
Gloria R Garcia, Murali Palangat, Josquin Moraly, et al.
Page
of 3